VAM
AGN

Visium Asset Management’s Allergan plc AGN Stock Holding History

Visium Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,000
Closed -$462K – 254
2016
Q2 		$462K Sell
2,000
-27,500
-93% -$6.34M 0.03% 273
2016
Q1 		$7.91M Buy
+29,500
New +$8.44M 0.13% 188

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Visium Asset Management's AGN Position: Q3 2016 in Review

Visium Asset Management sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 1,847 shares — an estimated $426K sold.

Visium Asset Management first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $441M in Q1 2014. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Visium Asset Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Visium Asset Management sold 1,847 Allergan plc shares in Q3 2016, an estimated $426K.
  • Visium Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • Visium Asset Management's Allergan plc position peaked at $441M in Q1 2014.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.